cemiplimab

Thu, 17 Aug 2023 09:11:01 -0400
Libtayo (cemiplimab for injection): in combination with platinum based chemotherapy for the first line treatment of adult patients with NSCLC whose tumours have no EGFR, ALK or ROS1 aberrations and is:- locally advanced where patients are not candidates for surgical resection or definitive chemoradiation, or - metastatic NSCLC.